NEW YORK, Nov. 29 (GenomeWeb News) - Serologicals subsidiary Chemicon International signed a semi-exclusive license to use RheoGene's RheoSwitch System for its stem cell biology products, Serologicals said yesterday.
Under this agreement, Chemicon can access the RheoSwitch technology to regulate the timing and level of gene expression in all types of eukaryotic cells. RheoGene will provide proprietary ecdysone-based receptors and molecule ligands for the system. Chemicon will apply the technology to generic cloning and expression reagents and to genes involved in cell differentiation.
Financial terms were not disclosed.